Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2025 ▲▼ | Q2 2025 ▲▼ | Change ▲▼ | Q1 2025 ▲▼ | Q2 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Roivant Sciences Ltd.SHS(ROIV) | 12,480,000 | 12,480,000 | 0 | $125.92M | $140.65M | 50.71% | +$14.73M |
| Insmed Incorporated(INSM) | 330,250 | 358,800 | +28,550 | $25.19M | $36.11M | 13.02% | +$10.91M |
| argenx SEADR(ARGX) | 0 | 29,000 | +29,000 | $0 | $15.99M | 5.76% | +$15.99M |
| EyePoint, Inc.(EYPT) | 1,481,977 | 1,352,837 | -129,140 | $8.03M | $12.73M | 4.59% | +$4.70M |
| Liquidia Corporation(LQDA) | 1,522,452 | 1,020,000 | -502,452 | $22.46M | $12.71M | 4.58% | -$9.75M |
| Ocular Therapeutix, Inc.(OCUL) | 920,199 | 817,699 | -102,500 | $6.75M | $7.59M | 2.74% | +$843.2K |
| Cullinan Therapeutics, Inc.(CGEM) | 878,897 | 868,897 | -10,000 | $6.65M | $6.54M | 2.36% | -$110.5K |
| Kymera Therapeutics, Inc.(KYMR) | 142,201 | 140,000 | -2,201 | $3.89M | $6.11M | 2.20% | +$2.22M |
| Mirum Pharmaceuticals, Inc.(MIRM) | 116,362 | 113,462 | -2,900 | $5.24M | $5.77M | 2.08% | +$532.0K |
| Scholar Rock Holding Corporation(SRRK) | 154,000 | 154,000 | 0 | $4.95M | $5.45M | 1.97% | +$503.6K |
| Enliven Therapeutics, Inc. | 253,838 | 245,838 | -8,000 | $5.00M | $4.93M | 1.78% | -$64.0K |
| Nurix Therapeutics, Inc.(NRIX) | 447,296 | 412,296 | -35,000 | $5.31M | $4.70M | 1.69% | -$617.8K |
| Agios Pharmaceuticals, Inc.(AGIO) | 139,732 | 139,732 | 0 | $4.09M | $4.65M | 1.68% | +$553.3K |
| Pharvaris N. V. COM | 245,496 | 244,283 | -1,213 | $3.85M | $4.30M | 1.55% | +$445.1K |
| Disc Medicine, Inc.(IRON) | 83,000 | 74,000 | -9,000 | $4.12M | $3.92M | 1.41% | -$201.1K |
| Allogene Therapeutics, Inc. | 2,368,186 | 2,635,000 | +266,814 | $3.46M | $2.98M | 1.07% | -$480.0K |
| Geron Corporation(GERN) | 0 | 716,000 | +716,000 | $0 | $1.01M | 0.36% | +$1.01M |
| Cidara Therapeutics Inc | 0 | 15,000 | +15,000 | $0 | $730.6K | 0.26% | +$730.6K |
| Yarrow Bioscience Inc(YARW) | 257,033 | 317,033 | +60,000 | $406.1K | $523.1K | 0.19% | +$117.0K |
| Intellia Therapeutics, Inc.(NTLA) | 232,781 | 0 | -232,781 | $1.66M | $0 | — | -$1.66M |
| Soleno Therapeutics, Inc. | 18,600 | 0 | -18,600 | $1.33M | $0 | — | -$1.33M |
| Blueprint Medicines Corporation | 38,500 | 0 | -38,500 | $3.41M | $0 | — | -$3.41M |